{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:06:33Z","timestamp":1788822393348,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012324","name":"University Hospitals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.cgh.2024.09.020","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T20:46:32Z","timestamp":1729802792000},"page":"1216-1227.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Calibration, Clinical Utility, and Specificity of Clinical Decision Support Tools in Inflammatory Bowel Disease"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6795-6328","authenticated-orcid":false,"given":"Dahham","family":"Alsoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Sabino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Verstockt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9942-3019","authenticated-orcid":false,"given":"S\u00e9verine","family":"Vermeire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2024.09.020_bib1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.020_bib2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S2468-1253(23)00075-4","article-title":"The economic burden of inflammatory bowel disease","volume":"8","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.020_bib3","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJMra1907607","article-title":"Newer biologic and small-molecule therapies for inflammatory bowel disease","volume":"385","author":"Baumgart","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2024.09.020_bib4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/apt.16723","article-title":"Trends in the use of biologicals and their treatment outcomes among patients with inflammatory bowel diseases \u2013 a Danish nationwide cohort study","volume":"55","author":"Zhao","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.09.020_bib5","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/apt.17145","article-title":"Therapeutic management and outcomes in inflammatory bowel diseases, 2010 to 2017 in cohorts from Denmark, Sweden and Norway","volume":"56","author":"Zhao","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.09.020_bib6","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/ecco-jcc\/jjab050","article-title":"Results of the Seventh Scientific Workshop of ECCO: precision medicine in IBD-disease outcome and response to therapy","volume":"15","author":"Verstockt","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.09.020_bib7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1053\/j.gastro.2018.05.039","article-title":"Development and validation of a scoring system to predict outcomes of vedolizumab treatment in patients with Crohn\u2019s disease","volume":"155","author":"Dulai","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.09.020_bib8","doi-asserted-by":"crossref","first-page":"S373","DOI":"10.14309\/01.ajg.0000592084.01472.42","article-title":"637 Clinical prediction model and decision support tool for ustekinumab in Crohn\u2019s disease","volume":"114","author":"Dulai","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.09.020_bib9","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1016\/j.cgh.2020.02.010","article-title":"Development and validation of clinical scoring tool to predict outcomes of treatment with vedolizumab in patients with ulcerative colitis","volume":"18","author":"Dulai","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.020_bib10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/apt.15609","article-title":"A clinical decision support tool may help to optimise vedolizumab therapy in Crohn\u2019s disease","volume":"51","author":"Dulai","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.09.020_bib11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ibd\/izab060","article-title":"Vedolizumab clinical decision support tool predicts efficacy of vedolizumab but not ustekinumab in refractory Crohn\u2019s disease","volume":"28","author":"Alric","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.09.020_bib12","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/ibd\/izab310","article-title":"Decision support tool identifies ulcerative colitis patients most likely to achieve remission with vedolizumab vs adalimumab","volume":"28","author":"Dulai","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.09.020_bib13","article-title":"Probability of response as defined by a clinical decision support tool is associated with lower healthcare resource utilization in vedolizumab-treated patients with Crohn\u2019s disease","volume":"4","author":"Dulai","year":"2022","journal-title":"Crohns Colitis 360"},{"key":"10.1016\/j.cgh.2024.09.020_bib14","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/ibd\/izac105","article-title":"Feasibility of a clinical decision support tool for ustekinumab to predict clinical remission and relapse in patients with Crohn\u2019s disease: a multicenter observational study","volume":"29","author":"Park","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.09.020_bib15","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/apt.17989","article-title":"Application of clinical decision support tools for predicting outcomes with vedolizumab therapy in patients with inflammatory bowel disease: a KASID multicentre study","volume":"59","author":"Kim","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.09.020_bib16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","article-title":"Topic Group \u2018Evaluating diagnostic tests and prediction models\u2019 of the STRATOS initiative. Calibration: the Achilles heel of predictive analytics","volume":"17","author":"Van Calster","year":"2019","journal-title":"BMC Medicine"},{"key":"10.1016\/j.cgh.2024.09.020_bib17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"10.1016\/j.cgh.2024.09.020_bib18","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2024.09.020_bib19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/0272989X14547233","article-title":"Calibration of risk prediction models: impact on decision-analytic performance","volume":"35","author":"Van Calster","year":"2015","journal-title":"Med Decis Making"},{"key":"10.1016\/j.cgh.2024.09.020_bib20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.7326\/0003-4819-157-4-201208210-00014","article-title":"Beyond the usual prediction accuracy metrics: reporting results for clinical decision making","volume":"157","author":"Localio","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2024.09.020_bib21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/bimj.201700067","article-title":"Variable selection \u2013 a review and recommendations for the practicing statistician","volume":"60","author":"Heinze","year":"2018","journal-title":"Biom J"},{"key":"10.1016\/j.cgh.2024.09.020_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/bimj.202200302","article-title":"Stability of clinical prediction models developed using statistical or machine learning methods","volume":"65","author":"Riley","year":"2023","journal-title":"Biom J"},{"key":"10.1016\/j.cgh.2024.09.020_bib23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s12916-023-03212-y","article-title":"Clinical prediction models and the multiverse of madness","volume":"21","author":"Riley","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.cgh.2024.09.020_bib24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/1471-0528.14170","article-title":"Key steps and common pitfalls in developing and validating risk models","volume":"124","author":"Wynants","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.cgh.2024.09.020_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s41512-017-0012-3","article-title":"Validation of prediction models: examining temporal and geographic stability of baseline risk and estimated covariate effects","volume":"1","author":"Austin","year":"2017","journal-title":"Diagn Progn Res"},{"key":"10.1016\/j.cgh.2024.09.020_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41512-016-0002-x","article-title":"Validation and updating of risk models based on multinomial logistic regression","volume":"1","author":"Van Calster","year":"2017","journal-title":"Diagn Progn Res"},{"key":"10.1016\/j.cgh.2024.09.020_bib27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/014107680209500220","article-title":"Decision making in health and medicine: integrating evidence and values","volume":"95","author":"Ulahannan","year":"2002","journal-title":"J R Soc Med"},{"key":"10.1016\/j.cgh.2024.09.020_bib28","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1053\/j.gastro.2014.07.022","article-title":"Crohn\u2019s disease evaluation and treatment: clinical decision tool","volume":"147","author":"Sandborn","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.09.020_bib29","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.cgh.2018.04.040","article-title":"Evidence to support monitoring of vedolizumab trough concentrations in patients with inflammatory bowel diseases","volume":"16","author":"Dreesen","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Supplement_1","key":"10.1016\/j.cgh.2024.09.020_bib30","doi-asserted-by":"crossref","first-page":"S439","DOI":"10.1093\/ecco-jcc\/jjx180.776","article-title":"P649 Comparison of the KU Leuven ustekinumab concentration assay and the antibodies-to-ustekinumab assay with assays developed at Janssen R& D and used in clinical studies of IBD patients","volume":"12","author":"Marini","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.09.020_bib31","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","article-title":"Topic Group \u2018Evaluating diagnostic tests and prediction models\u2019 of the STRATOS initiative. Calibration: the Achilles heel of predictive analytics","volume":"17","author":"Van Calster","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.cgh.2024.09.020_bib32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"10.1016\/j.cgh.2024.09.020_bib33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s12874-022-01801-8","article-title":"Methodological guidance for the evaluation and updating of clinical prediction models: a systematic review","volume":"22","author":"Binuya","year":"2022","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.cgh.2024.09.020_bib34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/bimj.201700067","article-title":"Variable selection \u2013 a review and recommendations for the practicing statistician","volume":"60","author":"Heinze","year":"2018","journal-title":"Biom J"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524009583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524009583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:12:39Z","timestamp":1762549959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356524009583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1542356524009583"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2024.09.020","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calibration, Clinical Utility, and Specificity of Clinical Decision Support Tools in Inflammatory Bowel Disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2024.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the AGA Institute","name":"copyright","label":"Copyright"}]}}